JPY 1105.0
(1.1%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.24 Billion | 1.68 Billion | 2.72 Billion | 5.66 Billion | 3.8 Billion | 1.34 Billion |
Net Income | 1.99 Billion | 3.22 Billion | 2.65 Billion | 2.04 Billion | 2.21 Billion | 2.79 Billion |
Depreciation & Amortization | 2.14 Billion | 1.95 Billion | 1.82 Billion | 1.66 Billion | 1.5 Billion | 1.43 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.3 Billion | -1.97 Billion | -664 Million | 2.95 Billion | 822 Million | -1.61 Billion |
Other non-cash items | 3.37 Billion | -1.51 Billion | -1.09 Billion | -995 Million | -735 Million | -1.27 Billion |
Investing Cash Flow | -2.45 Billion | -2.84 Billion | -2.33 Billion | -2.94 Billion | -1.12 Billion | -965 Million |
Investments in PPE | -2.25 Billion | -2.47 Billion | -2.53 Billion | -3.15 Billion | -1.41 Billion | -1.29 Billion |
Acquisitions | -90 Million | -330 Million | 213 Million | 181 Million | 218 Million | 333 Million |
Investment purchases | -110 Million | -155 Million | -5 Million | -4 Million | -5 Million | -5 Million |
Sales/Maturities of investments | 2 Million | 13 Million | -213 Million | 30 Million | 58 Million | 12 Million |
Other Investing Activities | -2 Million | 104 Million | 205 Million | 6 Million | 19 Million | -6 Million |
Financing Cash Flow | -1.88 Billion | -637 Million | -619 Million | -502 Million | -1.14 Billion | -1.28 Billion |
Debt repayment | -899 Million | -13 Million | -172 Million | -66 Million | -216 Million | -468 Million |
Dividends payments | -644 Million | -522 Million | -445 Million | -420 Million | -483 Million | -439 Million |
Common Stock Repurchased | -340 Million | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1 Million | -102 Million | -2 Million | -16 Million | -444 Million | -375 Million |
Accounts receivables | 150 Million | -2.1 Billion | -948 Million | 1.32 Billion | 686 Million | 445 Million |
Accounts payables | 16 Million | 1.1 Billion | 1.14 Billion | 749 Million | -1.43 Billion | 103 Million |
Inventory | 546 Million | -1 Billion | -896 Million | 927 Million | 1.44 Billion | -2.31 Billion |
Other working capital | 597 Million | 35 Million | 39 Million | -46 Million | 131 Million | 149 Million |
Cash at beginning of period | 6.19 Billion | 7.97 Billion | 8.16 Billion | 5.94 Billion | 4.4 Billion | 5.32 Billion |
Cash at end of period | 7.12 Billion | 6.19 Billion | 7.97 Billion | 8.16 Billion | 5.94 Billion | 4.4 Billion |
Capital Expenditure | -2.25 Billion | -2.47 Billion | -2.53 Billion | -3.15 Billion | -1.41 Billion | -1.29 Billion |
Effect of forex changes on cash | 20 Million | 16 Million | 34 Million | 3 Million | -4 Million | -10 Million |
Net cash flow / Change in cash | 931 Million | -1.77 Billion | -190 Million | 2.21 Billion | 1.53 Billion | -916 Million |
Free Cash Flow | 2.99 Billion | -790 Million | 194 Million | 2.5 Billion | 2.39 Billion | 43 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 486 Million | 1.99 Billion | 550 Million | 570 Million | 338 Million | 533 Million |
Depreciation & Amortization | - | 2.14 Billion | - | 546 Million | 538 Million | 507 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 1.3 Billion | - | - | - | - |
Other non-cash items | -486 Million | 3.37 Billion | -550 Million | -570 Million | -338 Million | -533 Million |
Investing Cash Flow | - | -2.45 Billion | - | - | - | - |
Investments in PPE | - | -2.25 Billion | - | - | - | - |
Acquisitions | - | -90 Million | - | - | - | - |
Investment purchases | - | -110 Million | - | - | - | - |
Sales/Maturities of investments | - | 2 Million | - | - | - | - |
Other Investing Activities | - | -2 Million | - | - | - | - |
Financing Cash Flow | - | -1.88 Billion | - | - | - | - |
Debt repayment | - | -899 Million | - | - | - | - |
Dividends payments | - | -644 Million | - | - | - | - |
Common Stock Repurchased | - | -340 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1 Million | - | - | - | - |
Accounts receivables | - | 150 Million | - | - | - | - |
Accounts payables | - | 16 Million | - | - | - | - |
Inventory | - | 546 Million | - | - | - | - |
Other working capital | - | 597 Million | - | - | - | - |
Cash at beginning of period | - | 6.19 Billion | - | 3.9 Billion | 4.4 Billion | 6.19 Billion |
Cash at end of period | - | 7.12 Billion | - | 5.39 Billion | 3.9 Billion | 4.4 Billion |
Capital Expenditure | - | -2.25 Billion | - | - | - | - |
Effect of forex changes on cash | - | 20 Million | - | - | - | - |
Net cash flow / Change in cash | - | 931 Million | - | 1.49 Billion | -498 Million | -1.78 Billion |
Free Cash Flow | - | 2.99 Billion | - | 1.09 Billion | 1.07 Billion | 1.01 Billion |
E0E
MRUS
4093
WELL
MEDCL
HMS